Basic Science: Oncology

Moderated Poster Session

MP1-5 - Preoperative Neutrophil / Lymphocyte ratio (NLR) as a prognosticator in upper tract urothelial carcinoma (UTUC) patients treated conservatively: A retrospective evaluation

Thursday, September 20
4:00 PM - 6:00 PM
Location: Room 241

Introduction & Objective :

To evaluate the potential prognostic value of neutrophil / lymphocyte ratio (NLR - an expression of the involvement of systemic inflammation in neoplastic growth + progression) in conservatively treated UTUC patients.


Methods :

130 consecutive patients who underwent uretero-renoscopy and RIRS (retrograde intra renal surgery) for UTUC, were retrospectively evaluated.


From patient records, the following values (performed preoperatively): white blood cells (WBC), platelet (PLT), neutrophil (N), lymphocyte (L) counts, were collected for post-hoc analysis. NLR was derived by dividing N by L counts.


These data were compared with tumor characteristics: stage (Ta vs. T1), grade (G1 vs. ≥G2), focality (single vs. multiple), site (ureter vs. kidney vs. kidney+ureter), and size (≤1cm vs.>1 cm).


The endpoints were: recurrence at first follow-up, multiple recurrences during follow-up, and progression (Grade+/-Stage).


They were stratified by the NLR cut-off point, according to the receiver operating characteristic analysis.


T-test and chi-square test were used to evaluate parametric and non parametric variables. Statistical significance was considered at p < 0.05


Results :

The mean NLR value was 3.48±1.92.


Significantly higher NLR values were observed in patients with ≥pT1 (p=0.0001), HG (p=0.0009), multifocality (p=0.028), >1 cm tumor (p=0.0001).


The optimum cut-off value for NLR was 3 for all endpoints.


Patients with NLR >3, exhibited significantly higher; risk of recurrence at first follow-up (p=0.007, OR 2.94); risk of multiple recurrences (p=0.006, OR 1.54); and risk of disease progression (p=0.04, OR 5.00).


Conclusions :

The preoperative evaluation of NLR provides valuable prognostic information for the selection and clinical management of conservatively treated UTUC patients.


These data show that NLR >3 was associated with higher recurrence and progression rates.


It may identify those needing more frequent and endoscopic follow-up with biopsies, and lower thresholds to conversion to more aggressive surgical strategies except in imperative situations. Prospective multicenter studies with larger study populations are needed to validate the role of NLR >3, as a prognosticator of recurrence and progression in patients with UTUC treated conservatively, before incorporation into international practice guidelines.

Lorenzo Defidio

Chief of Urology
Cristo Re Hospital, Dept. of Urology, Rome, Italy

Lorenzo Defidio, MD, FEBU
Chief of Urology , Cristo Re Hospital, Rome
Professor of Urology at the Catholic University in Rome
Director Center of Fellowship in Endourology, endorsed by the Endourological Society
Director Center of Training Network of the La Sapienza University in Rome

Presentation(s):

    Send Email for Lorenzo Defidio

    Mauro De Dominicis

    Cristo Re Hospital, Dept. of Urology, Rome, Italy

    Presentation(s):

      Send Email for Mauro De Dominicis

      Michele Antonucci

      Cristo Re Hospital, Dept. of Urology, Rome, Italy

      Presentation(s):

        Send Email for Michele Antonucci

        Anup Patel

        Presentation(s):

          Send Email for Anup Patel


          Assets

          MP1-5 - Preoperative Neutrophil / Lymphocyte ratio (NLR) as a prognosticator in upper tract urothelial carcinoma (UTUC) patients treated conservatively: A retrospective evaluation



          Attendees who have favorited this

          Please enter your access key

          The asset you are trying to access is locked. Please enter your access key to unlock.

          Send Email for MP1-5 - Preoperative Neutrophil / Lymphocyte ratio (NLR) as a prognosticator in upper tract urothelial carcinoma (UTUC) patients treated conservatively: A retrospective evaluation